BioArctic AB
STO:BIOA B
BioArctic AB
STO:BIOA B
Price:
320.2
SEK
-2.67%
Market Closed
Market Cap:
kr28.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
BioArctic AB
STO:BIOA B
|
SE |
Balance Sheet
Balance Sheet Decomposition
BioArctic AB
BioArctic AB
Balance Sheet Decomposition is not available for
BioArctic AB
BioArctic AB
Balance Sheet
BioArctic AB
BioArctic AB
Currency: SEK
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
693
|
1 110
|
917
|
1 113
|
1 000
|
848
|
805
|
612
|
513
|
1 040
|
|
| Cash |
693
|
0
|
0
|
0
|
0
|
0
|
805
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
1 110
|
917
|
1 113
|
1 000
|
848
|
0
|
612
|
513
|
1 040
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
500
|
266
|
1 150
|
|
| Total Receivables |
2
|
0
|
4
|
19
|
6
|
9
|
8
|
7
|
107
|
0
|
|
| Accounts Receivables |
1
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
71
|
0
|
|
| Other Receivables |
2
|
0
|
0
|
18
|
6
|
6
|
8
|
7
|
36
|
0
|
|
| Other Current Assets |
5
|
20
|
461
|
13
|
3
|
4
|
7
|
34
|
623
|
297
|
|
| Total Current Assets |
699
|
1 130
|
1 382
|
1 144
|
1 008
|
862
|
821
|
1 153
|
1 011
|
2 487
|
|
| PP&E Net |
6
|
7
|
9
|
37
|
40
|
34
|
35
|
31
|
97
|
83
|
|
| PP&E Gross |
6
|
7
|
9
|
37
|
40
|
34
|
35
|
31
|
97
|
0
|
|
| Accumulated Depreciation |
13
|
13
|
15
|
24
|
35
|
48
|
63
|
77
|
62
|
0
|
|
| Long-Term Investments |
3
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
4
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Total Assets |
708
N/A
|
1 140
+61%
|
1 393
+22%
|
1 183
-15%
|
1 050
-11%
|
898
-15%
|
858
-4%
|
1 186
+38%
|
1 112
-6%
|
2 575
+132%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
12
|
8
|
15
|
8
|
14
|
12
|
21
|
30
|
50
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
31
|
43
|
45
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
6
|
7
|
8
|
9
|
3
|
13
|
16
|
|
| Other Current Liabilities |
631
|
491
|
328
|
135
|
87
|
81
|
10
|
49
|
67
|
505
|
|
| Total Current Liabilities |
643
|
499
|
343
|
149
|
109
|
101
|
71
|
125
|
176
|
521
|
|
| Long-Term Debt |
0
|
0
|
0
|
21
|
14
|
8
|
1
|
2
|
41
|
28
|
|
| Deferred Income Tax |
4
|
5
|
33
|
39
|
21
|
0
|
0
|
12
|
0
|
59
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
647
N/A
|
504
-22%
|
375
-26%
|
209
-44%
|
143
-32%
|
109
-24%
|
72
-34%
|
140
+94%
|
217
+55%
|
608
+181%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
|
| Retained Earnings |
60
|
73
|
560
|
560
|
560
|
786
|
784
|
1 044
|
892
|
0
|
|
| Other Equity |
1
|
561
|
456
|
413
|
346
|
1
|
1
|
1
|
1
|
1 967
|
|
| Total Equity |
61
N/A
|
636
+947%
|
1 018
+60%
|
974
-4%
|
907
-7%
|
789
-13%
|
786
0%
|
1 047
+33%
|
895
-14%
|
1 967
+120%
|
|
| Total Liabilities & Equity |
708
N/A
|
1 140
+61%
|
1 393
+22%
|
1 183
-15%
|
1 050
-11%
|
898
-15%
|
858
-4%
|
1 186
+38%
|
1 112
-6%
|
2 575
+132%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
63
|
88
|
88
|
88
|
88
|
88
|
88
|
88
|
88
|
89
|
|
Switch to:
Switch to:
See Also
Discover More
